← Back to Search

Nutritional Supplements

Curcumin, Omega-3, and Vitamin D Supplements for Healthy Subjects (PASCOD3 Trial)

N/A
Waitlist Available
Led By Liam O'Neil, MD, MHSc
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Verified to be ACPA+ based on serum testing without RA
Age between 18 and 65 years old
Must not have
Scheduled elective surgery or other procedures requiring general anaesthesia during the trial
Self-reported body weight change of greater than 3.5 kg within the past 3 months, unexplained by medical history
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at day 0 and day 84
Awards & highlights
No Placebo-Only Group

Summary

This trial will investigate if taking curcumin, omega-3, and vitamin D supplements for 3 months can change the level of a specific antibody in the body. Participants will take the supplements daily

Who is the study for?
This trial is for healthy individuals who have a specific antibody called ACPA in their blood. Participants will be taking a combination of supplements—curcumin, omega-3, and vitamin D—for three months to see if it affects the levels of ACPA.
What is being tested?
The study tests whether consuming curcumin, omega-3, and vitamin D (COD) can lower Anti-cyclic citrullinated peptide antibody (ACPA) levels. It's an open-label pre-post design where participants know they're taking the supplements and must follow up with the clinic on days 0 and 84.
What are the potential side effects?
Potential side effects from COD may include digestive discomfort such as nausea or diarrhea, allergic reactions, or changes in mood or sleep due to omega-3 or vitamin D. The full range of side effects will be monitored throughout the trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My blood test shows ACPA positive but I don't have rheumatoid arthritis.
Select...
I am between 18 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have surgery planned that will need general anesthesia during the trial.
Select...
I have lost or gained more than 3.5 kg in the last 3 months without a known reason.
Select...
I will not take the treatments every day.
Select...
I haven't had serious autoimmune, heart, lung, liver, or GI issues, or cancer treatments in the last year.
Select...
I am not pregnant, breastfeeding, or planning to become pregnant during the trial.
Select...
I am a woman who can have children and do not agree to use birth control during the trial.
Select...
I have not had a stomach ulcer or severe acid reflux in the last 6 weeks.
Select...
I have had a viral or bacterial infection in the last 4 weeks and am not fully recovered.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at day 0 and day 84
This trial's timeline: 3 weeks for screening, Varies for treatment, and at day 0 and day 84 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
ACPA levels
Secondary study objectives
Side-effect profile of COD
Other study objectives
ALP
ALT
AST
+29 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: curcumin, omega-3, and vitamin D (COD)Experimental Treatment1 Intervention
Acumin™Turmeric Complex/Dr. D's Ultra BioTurmeric: 500 mg/day (oral, 2 tablets taken by mouth), Vitamin D: 2500 IU/day (oral, 1 tablet taken by mouth), Omega-3: 900 mg day (oral, 1 tablet taken by mouth)

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
618 Previous Clinical Trials
206,659 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,386 Previous Clinical Trials
26,515,925 Total Patients Enrolled
Liam O'Neil, MD, MHScPrincipal InvestigatorUniversity of Manitoba
~33 spots leftby Jul 2026